These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1615501)

  • 1. Serotonin is involved in some effects of erythropoietin.
    Azzadin A; Bialkowska A; Pawlak D; Chabielska E; Mazerska M; Mysliwiec M; Buczko W
    Thromb Res; 1992 Mar; 65(4-5):657-61. PubMed ID: 1615501
    [No Abstract]   [Full Text] [Related]  

  • 2. A study of platelet functions, some hemostatic and fibrinolytic parameters in relation to serotonin in hemodialyzed patients under erythropoietin therapy.
    Malyszko J; Malyszko JS; Borawski J; Rydzewski A; Kalinowski M; Azzadin A; Mysliwiec M; Buczko W
    Thromb Res; 1995 Jan; 77(2):133-43. PubMed ID: 7740505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin does not increase whole-blood platelet aggregation in vitro.
    Taylor JE; Belch JJ; Henderson IS; Stewart WK
    Nephrol Dial Transplant; 1994; 9(5):556-8. PubMed ID: 8090338
    [No Abstract]   [Full Text] [Related]  

  • 4. Recombinant human erythropoietin increases blood pressure, platelet aggregability and platelet free calcium mobilisation in uraemic children: a possible link?
    Van Geet C; Van Damme-Lombaerts R; Vanrusselt M; de Mol A; Proesmans W; Vermylen J
    Thromb Haemost; 1990 Aug; 64(1):7-10. PubMed ID: 2274929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between dipyridamole and prostaglandin E1 with ADP-induced aggregation of rat platelet in whole blood.
    Touqui L; Hatmi M; Vargaftig BB
    Thromb Haemost; 1984 Jul; 51(3):410. PubMed ID: 6541815
    [No Abstract]   [Full Text] [Related]  

  • 6. The intraperitoneal effects of 5-hydroxytryptamine on haemodynamics, gastric mucosal blood flow and platelet aggregation.
    Cho CH; Mei QB; Kaan SK
    Eur J Pharmacol; 1994 Apr; 256(1):9-15. PubMed ID: 8026564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin and blood pressure.
    Pagel H; Jelkmann W; Weiss C
    Horm Metab Res; 1989 Apr; 21(4):224. PubMed ID: 2753475
    [No Abstract]   [Full Text] [Related]  

  • 8. Recombinant human erythropoietin shortens the bleeding time and corrects the abnormal platelet aggregation in hemodialysis patients.
    el-Shahawy MA; Francis R; Akmal M; Massry SG
    Clin Nephrol; 1994 May; 41(5):308-13. PubMed ID: 8050212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comparison between ADP-induced aggregation and noradrenaline plus 5-hydroxytryptamine induced aggregation.
    Takano S; Suzuki T
    Fukushima J Med Sci; 1978 Feb; 25(1-2):1-7. PubMed ID: 748135
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings: Time-dependent potentiation and inhibition by 5-hydroxytryptamine of platelet aggregation induced by ADP.
    Michal F; Motamed M
    Br J Pharmacol; 1975 Jun; 54(2):221P-222P. PubMed ID: 1148513
    [No Abstract]   [Full Text] [Related]  

  • 11. Metergoline: a strong inhibitor of rat thrombocyte aggregation "in vitro.".
    Doni MG
    Haematologica; 1980 Dec; 65(6):717-24. PubMed ID: 6790362
    [No Abstract]   [Full Text] [Related]  

  • 12. High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO).
    Kirkeby A; Torup L; Bochsen L; Kjalke M; Abel K; Theilgaard-Monch K; Johansson PI; Bjørn SE; Gerwien J; Leist M
    Thromb Haemost; 2008 Apr; 99(4):720-8. PubMed ID: 18392330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proceedings: Refractoriness in blood platelets: effect of prior exposure to aggregating agents on subsequent aggregation responses.
    Evans RJ; Gordon JL
    Br J Pharmacol; 1974 May; 51(1):123P. PubMed ID: 4441772
    [No Abstract]   [Full Text] [Related]  

  • 14. Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.
    Michal F; Motamed M
    Br J Pharmacol; 1976 Feb; 56(2):209-18. PubMed ID: 1252669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Importance of prostaglandins and cyclic nucleotides in altering thrombocyte aggregation induced by thyroxine].
    Kirichuk VF
    Gematol Transfuziol; 1986 Jun; 31(6):31-4. PubMed ID: 3732780
    [No Abstract]   [Full Text] [Related]  

  • 16. Opposite effect of lysine on platelet aggregation induced by arachidonate and by other aggregants.
    Ts'ao C; Hart SJ; Krajewski DV; Sorensen PG
    Thromb Haemost; 1982 Aug; 48(1):78-83. PubMed ID: 6813998
    [No Abstract]   [Full Text] [Related]  

  • 17. Recombinant human erythropoietin increases platelet aggregation in chronic hemodialysis patients.
    Sayinalp N; Erdem Y; Ilhami Ozcebe O; Büyükaşik Y; Cağlar S; Dündar SV
    Thromb Res; 1998 May; 90(4):195-8. PubMed ID: 9692619
    [No Abstract]   [Full Text] [Related]  

  • 18. The serotonergic mechanisms are not involved in the inhibitory effect of captopril on rat platelet aggregation.
    Malinowska B; Chabielska E; Pietraszek MH; Buczko W
    Haemostasis; 1990; 20(1):48-53. PubMed ID: 2182479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative studies on the induction of blood platelet aggregation by procollagen, serotonin and ADP and the mutual interaction of those drugs].
    Scharrer I; Kreft U; Breddin K
    Verh Dtsch Ges Inn Med; 1972; 78():1539-42. PubMed ID: 4677217
    [No Abstract]   [Full Text] [Related]  

  • 20. Serotonin-2A receptor gene polymorphisms are associated with serotonin-induced platelet aggregation.
    Shimizu M; Kanazawa K; Matsuda Y; Takai E; Iwai C; Miyamoto Y; Hashimoto M; Akita H; Yokoyama M
    Thromb Res; 2003; 112(3):137-42. PubMed ID: 14967409
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.